Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical College: Hospital for Special Surgery - Rheumatology Division
mi
from
New York, NY
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College: Hospital for Special Surgery - Rheumatology Division
mi
from
New York, NY
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Penn State University
mi
from
Hershey, PA
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Penn State University
mi
from
Hershey, PA
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
University of Colorado
mi
from
Denver, CO
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
New York University Langone Medical Center
mi
from
New York, NY
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
(AOA) Arthritis & Osteoporosis Associates
mi
from
Freehold, NJ
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
(AOA) Arthritis & Osteoporosis Associates
mi
from
Freehold, NJ
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Advanced Pharma Clinical Research
mi
from
Miami, FL
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Advanced Pharma Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Arthritis Northwest Rheumatology
mi
from
Spokane, WA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Arthritis Northwest Rheumatology
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Arthritis Research of Florida, Inc.
mi
from
Palm Harbor, FL
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Arthritis Research of Florida, Inc.
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Box Arthritis and Rheumatology of the Carolina's
mi
from
Charlotte, NC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Box Arthritis and Rheumatology of the Carolina's
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center of Reading, LLP
mi
from
Wyomissing, PA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of Reading, LLP
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Denver Arthritis Center
mi
from
Denver, CO
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Denver Arthritis Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Desert Medical Advances
mi
from
Palm Desert, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Desert Medical Advances
mi
from
Palm Desert, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Indiana University Health
mi
from
Indianapolis, IN
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Indiana University Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Inlande Rheumatology Clinical Trials
mi
from
Upland, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Inlande Rheumatology Clinical Trials
mi
from
Upland, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Innovative Health Research
mi
from
Las Vegas, NV
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Innovative Health Research
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Low Country Research Center
mi
from
North Charleston, SC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Low Country Research Center
mi
from
North Charleston, SC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Medvin Clinical Research
mi
from
Covina, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Medvin Clinical Research
mi
from
Covina, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
New England Research Associates, Llc
mi
from
Trumbull, CT
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
New England Research Associates, Llc
mi
from
Trumbull, CT
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
New Horizon Research Center
mi
from
Miami, FL
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
New Horizon Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Oklahoma Arthritis Center
mi
from
Edmond, OK
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Oklahoma Arthritis Center
mi
from
Edmond, OK
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Paramount Medical Research
mi
from
Middleburg Heights, OH
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Paramount Medical Research
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Pharmquest
mi
from
Greensboro, NC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Pharmquest
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Physician Research Collaboration
mi
from
Lincoln, NE
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Physician Research Collaboration
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Pmg Research Of Salisbury
mi
from
Salisbury, NC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Pmg Research Of Salisbury
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
ProHealth Partners Medical Group
mi
from
Long Beach, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
ProHealth Partners Medical Group
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Shanahan Rheumatology and Immunotherapy, PLLC
mi
from
Raleigh, NC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Shanahan Rheumatology and Immunotherapy, PLLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Sun Research Institute
mi
from
San Antonio, TX
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Sun Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Tekton Research
mi
from
Austin, TX
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Tekton Research
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Arthritis and Diabetes Clinic, Inc
mi
from
Monroe, LA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Arthritis and Diabetes Clinic, Inc
mi
from
Monroe, LA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Wallace Rheumatic Study Center
mi
from
Los Angeles, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Wallace Rheumatic Study Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
West Michigan Rheumatology
mi
from
Grand Rapids, MI
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
West Michigan Rheumatology
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Westroads Clinical Research - Omaha
mi
from
Omaha, NE
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Westroads Clinical Research - Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Daejeon,
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Daejeon,
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
TriWest Research Associates, LLC
mi
from
El Cajon, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
TriWest Research Associates, LLC
mi
from
El Cajon, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Clayton Medical Research
mi
from
Saint Louis, MO
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Clayton Medical Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Mountain State Clinical Research
mi
from
Clarksburg, WV
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Mountain State Clinical Research
mi
from
Clarksburg, WV
Click here to add this to my saved trials
Nelfinavir in Systemic Lupus Erythematosus
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Nelfinavir in Systemic Lupus Erythematosus
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Nelfinavir in Systemic Lupus Erythematosus
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status: Enrolling
Updated:  12/31/1969
UCLA David Geffen School of Medicine
mi
from
Los Angeles, CA
Nelfinavir in Systemic Lupus Erythematosus
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status: Enrolling
Updated: 12/31/1969
UCLA David Geffen School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials